Artificial intelligence at the service of Laval Citizens
An innovation in the municipal world
The city of Laval is working with artificial intelligence tools to benefit its citizens. Having started its digital transformation...
Laval is hoping Moderna will build a facility at Cité de la Biotech
U.S.-based vaccine maker has benefited hugely from the COVID-19 pandemic
With one of its most prized pieces of industrial parkland primed and ready to welcome...
JGH research offers hope to help reduce COVID-19 suffering
Consortium pursues promise seen in boosting levels of protein ‘OAS1’
An international consortium, including scientists from the Lady Davis Institute at the Jewish General Hospital...
INRS study links prostate cancer to obesity
Prostate cancer is the most common form of cancer among Canadian men and the third leading cause of cancer death. Abdominal obesity appears to...
Local engineering student awarded $5,000 bursary by foundation
Liliya Boyadjieva hopes to make breakthroughs in health technology
A young Laval woman with aspirations to advance in the traditionally male-dominated domain of electrical engineering...
Laval launches Phase II of its ‘Biotech City’ science park project
City believes pandemic could stimulate an upswing in science research
The City of Laval says it is going ahead with a second phase of its...
Laval-based Nexelis partners with China’s JOINN for COVID-19 studies
Bioanalytics lab becomes first specialized in vaccine testing to set up in China
Laval-based Nexelis, specializing in vaccine testing research and development, announced last week...
The virus, the vaccine and the variant
Catching up with Dr. Chris Karatzios
If the title of this article conjures memories of westerns with harmonica soundtracks, it’s because I meant it to...
Breakthrough in HIV therapy research for Laval-based INRS
Prompted by the need to improve conventional treatments for people infected with the human immunodeficiency virus (HIV-1), a team from the Laval-based Institut national...